Overview

Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction(ThyroHeart-AMI)

Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Based on accumulating evidences showing that hypothyroid status is associated with poor prognosis among acute myocardial infarction (AMI) patients, the study is designed to evaluate whether replacement treatment with levothyroxine could have beneficial effects on patients with AMI and hypothyroidism. This is a multicenter prospective computerized-randomized trial stratified by ejection fraction with a 1:1 ratio to levothyroxine group or standard therapy group.
Phase:
Phase 4
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborators:
Beijing Anzhen Hospital
Beijing Chao Yang Hospital
Beijing Friendship Hospital
Beijing Municipal Science & Technology Commission
Peking Union Medical College Hospital
Peking University Third Hospital
The Luhe Teaching Hospital of the Capital Medical University